A novel genome-reduced microorganism and a method of producing thereof
KR20180121469A
Composition for enhancing immune response comprising ginsenoside F1
US2019224278A1
Producing method of antimicrobial peptide with enhanced adhesion and uses thereof
KR20190089707A
Producing method of antimicrobial peptide with enhanced adhesion and uses thereof
KR20200045591A
Composition for treating wound comprising Gypenoside LXXV
WO2019017722A2
Method for producing ginsenoside from gynostemma pentaphyllum-derived adventitious root
KR20190131376A
Increased production of ginsenosides through yeast cell NADPH-related biosynthetic pathway
KR20190046203A
A composition for solubilization of target proteins and use thereof
KR101968004B1
Mass producing method of ginsenoside Rh2 mix
KR20170113519A
Method for screening activator of mitochondria activity
KR20190017099A
Increased production of ginsenosides through yeast cell protein-folding machinery improvement
KR20180122502A
Increased production of ginsenosides through yeast cell organelle improvement
CN107684556A
Prevention of hcc or therapeutic composition comprising GF2
KR20180043421A
Method and domain information for exploring hotspot of expression of recombinant protein in cell line using lentivirus based next-generation sequencing
KR20180031875A
Exploring hotspot method for expression of recombinant protein in cell line using next-generation sequencing
KR20180000379A
Composition for enhancing immune response comprising ginsenoside F1
CA2962201A1
Composition for preventing or treating vascular leak syndrome
WO2017191856A1
Antidiabetic effect of gypenoside 75
KR20170073781A
A method for production of minor ginsenosides using ginsenoside glycosidase
KR20170013793A
The composition containing ginsenoside F1 for removing amyloid plaques
